Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in CashDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Amortization - Deferred ChargesCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

CNO Financial (CNO) Shares Repurchased (2016 - 2026)

CNO Financial (CNO) has 15 years of Shares Repurchased data on record, last reported at $73.3 million in Q1 2026.

  • On a quarterly basis, Shares Repurchased fell 33.54% to $73.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was $294.4 million, a 16.29% decrease, with the full-year FY2025 number at $331.4 million, up 10.39% from a year prior.
  • Shares Repurchased reached $73.3 million in Q1 2026 per CNO's latest filing, up from $60.2 million in the prior quarter.
  • Over the last five years, Shares Repurchased for CNO hit a ceiling of $110.3 million in Q1 2025 and a floor of $9.9 million in Q4 2022.
  • A 5-year average of $62.4 million and a median of $60.3 million in 2022 define the central range for Shares Repurchased.
  • Peak YoY movement for Shares Repurchased: crashed 91.6% in 2022, then surged 610.1% in 2023.
  • Tracing CNO's Shares Repurchased over 5 years: stood at $9.9 million in 2022, then soared by 610.1% to $70.3 million in 2023, then skyrocketed by 30.44% to $91.7 million in 2024, then plummeted by 34.35% to $60.2 million in 2025, then grew by 21.76% to $73.3 million in 2026.
  • Business Quant data shows Shares Repurchased for CNO at $73.3 million in Q1 2026, $60.2 million in Q4 2025, and $60.6 million in Q3 2025.